Frequently Asked Questions

Get answers to the most common questions about weight loss peptides including Semaglutide, Tirzepatide, and Liraglutide.

Click any question to expand the answer.

The Basics

What are GLP-1 peptides and how do they work?

GLP-1 (glucagon-like peptide-1) agonists are medications that mimic a natural hormone your body produces after eating. They work through multiple mechanisms:

  • Appetite suppression: Activate receptors in the brain that control hunger and satiety
  • Delayed gastric emptying: Slow how quickly food leaves your stomach, keeping you full longer
  • Blood sugar control: Improve insulin sensitivity and reduce glucose production
  • Reduced cravings: Decrease food-seeking behavior and reward response to food

The result is a 20-30% reduction in caloric intake without conscious effort, leading to 15-22% weight loss over 68 weeks.

Which peptide is best: Tirzepatide, Semaglutide, or Liraglutide?

It depends on your priorities:

  • Tirzepatide (Mounjaro/Zepbound): Best for maximum weight loss (20-22%). Newest option with less long-term data. Weekly injection. $1,000-1,400/month.
  • Semaglutide (Ozempic/Wegovy): Best balance of efficacy (15-17%) and safety data. Most extensively studied. Proven cardiovascular benefits. Weekly injection. $900-1,400/month.
  • Liraglutide (Saxenda): Best for those prioritizing established safety (10+ years data). Lowest weight loss (8-10%). Daily injection. $1,300-1,500/month.

Most providers recommend starting with semaglutide as the best balance of efficacy, safety data, and cost. If results are insufficient, switching to tirzepatide is straightforward.

See detailed comparison →

How much weight will I lose?

Clinical trial results:

  • Tirzepatide: 20-22% average weight loss (48-52 lbs for a 240 lb person)
  • Semaglutide: 15-17% average weight loss (36-41 lbs for a 240 lb person)
  • Liraglutide: 8-10% average weight loss (19-24 lbs for a 240 lb person)

Individual results vary based on starting weight, adherence, lifestyle factors, and genetics. Some patients lose significantly more, others less.

💡 Realistic expectations: Most weight loss occurs in the first 68 weeks. After that, you'll reach a plateau and need maintenance strategies to prevent regain.

Calculate your expected weight loss →

How long does it take to see results?

Timeline of results:

  • Week 1: Appetite reduction begins, 2-5 lbs loss (mostly water)
  • Weeks 2-4: Consistent appetite suppression, 1-2 lbs/week loss
  • Weeks 5-12: Noticeable physical changes, 8-15 lbs total loss
  • Weeks 13-24: Significant transformation, 15-25 lbs total loss
  • Weeks 25-52: Major results visible, 25-40 lbs total loss
  • Weeks 53-68: Approaching maximum results, 30-50+ lbs total loss

Most dramatic results occur between weeks 12-40 when you're on higher doses and losing 1-2 lbs per week consistently.

Eligibility & Access

Do I qualify for weight loss peptides?

FDA-approved criteria:

  • BMI ≥30 (obesity), OR
  • BMI ≥27 (overweight) with at least one weight-related condition (diabetes, high blood pressure, high cholesterol, sleep apnea, cardiovascular disease)
  • Age 18+ (some approved for 12+)
  • No contraindications

⚠️ You do NOT qualify if you have:

  • Personal or family history of medullary thyroid cancer
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis
  • Severe gastrointestinal disease
  • Pregnant, breastfeeding, or planning pregnancy
Will insurance cover weight loss peptides?

Insurance coverage varies significantly:

  • For diabetes: Most insurance plans cover Ozempic (semaglutide) and Mounjaro (tirzepatide) with copays of $25-100/month
  • For weight loss only: Coverage is limited. Many plans exclude Wegovy and Zepbound entirely
  • Medicare: Does NOT cover weight loss medications by law
  • Medicaid: Varies by state; most don't cover for weight loss

To maximize insurance coverage:

  • Get prior authorization from your provider
  • Document failed diet/exercise attempts
  • Emphasize weight-related health conditions
  • Consider using diabetes indication if you have prediabetes/diabetes
  • Appeal denials with medical necessity documentation

Without insurance: Expect $900-1,500/month retail pricing.

What about compounded versions?

Compounded semaglutide and tirzepatide became widely available in 2022-2024 due to FDA-declared shortages, typically costing $200-400/month.

⚠️ Important considerations:

  • Not FDA-approved: Made under 503B compounding exemption, not subject to FDA approval process
  • Variable quality: Purity, sterility, and accurate dosing vary between compounding pharmacies
  • Different salt forms: May contain semaglutide sodium instead of semaglutide base (different dosing)
  • FDA warnings: FDA has issued warnings about adverse events from compounded GLP-1 agonists
  • Temporary availability: May become unavailable when shortages resolve
  • No insurance coverage: Always out-of-pocket

Recommendation: Use FDA-approved brand name versions when possible, especially if you have insurance coverage or can afford the cost. If using compounded versions, choose reputable 503B compounding pharmacies with third-party testing.

Side Effects & Safety

What are the most common side effects?

Common side effects (30-45% of patients):

  • Nausea (30-40%): Most common, usually improves after 4-8 weeks
  • Vomiting (10-15%): Typically mild, worse during dose increases
  • Diarrhea (15-20%): Usually resolves within 2-4 weeks
  • Constipation (20-25%): Can be persistent, managed with fiber/water
  • Abdominal pain (10-15%): Usually mild cramping
  • Fatigue (10-15%): Often due to reduced caloric intake
  • Heartburn/GERD (5-10%): Due to delayed gastric emptying

Most side effects:

  • Occur during first 8 weeks and dose increases
  • Improve significantly by week 12
  • Are manageable with dietary modifications
  • Resolve completely after stopping medication

💡 Minimizing side effects: Eat slowly, choose bland low-fat foods, stay hydrated, don't skip doses, and stay at lower doses longer if needed.

What are the serious risks?

Serious but rare side effects (<1-2% of patients):

  • Pancreatitis: Severe abdominal pain radiating to back. Requires immediate medical attention. Risk: 0.2-0.5%
  • Gallbladder disease: Rapid weight loss increases gallstone risk. May require surgery. Risk: 1-2%
  • Diabetic retinopathy worsening: Rapid blood sugar improvement can temporarily worsen eye disease in diabetics. Risk: 1-2% in diabetics
  • Kidney problems: Dehydration from vomiting/diarrhea can affect kidney function. Risk: <1%
  • Thyroid tumors: Seen in animal studies, not confirmed in humans. Black box warning. Risk: Unknown
  • Suicidal thoughts: Rare reports, causation unclear. Risk: <0.1%

⚠️ Seek immediate medical attention if you experience:

  • Severe abdominal pain (especially upper abdomen radiating to back)
  • Persistent vomiting (unable to keep down fluids for 24 hours)
  • Signs of gallbladder disease (right upper abdominal pain after eating)
  • Vision changes (especially if diabetic)
  • Severe allergic reaction (difficulty breathing, swelling)
  • Suicidal thoughts or severe depression
  • Lump in neck or difficulty swallowing
Can I take these medications long-term?

Yes, many patients use GLP-1 agonists long-term or indefinitely.

Long-term safety data:

  • Liraglutide: 10+ years of data, well-established safety profile
  • Semaglutide: 7+ years of data (since 2017 diabetes approval)
  • Tirzepatide: 2+ years of data (approved 2022)

Why long-term use may be necessary:

  • Weight regain is common after stopping (50-70% regain within 1 year)
  • Appetite returns to baseline or higher
  • Metabolic rate decreases with weight loss
  • Hormonal changes favor weight regain

Think of it like blood pressure medication: Many patients require long-term treatment to maintain results, and that's okay. The health benefits of sustained weight loss outweigh the risks of long-term medication use for most patients.

Dosing & Administration

How do I inject these medications?

All GLP-1 agonists come in pre-filled injection pens that are easy to use at home.

Step-by-step injection process:

  1. Remove pen from refrigerator 30 minutes before injection (room temperature reduces pain)
  2. Choose injection site: abdomen (2 inches from belly button), front of thigh, or back of upper arm
  3. Clean site with alcohol swab and let dry
  4. Pinch skin and insert needle at 90-degree angle
  5. Press button to inject (takes 5-10 seconds)
  6. Hold for 5 seconds after injection completes
  7. Remove needle and apply pressure with gauze (don't rub)
  8. Dispose of pen in sharps container

💡 Tips for easier injections:

  • Rotate injection sites (don't use same spot twice in a row)
  • Inject slowly to reduce pain
  • Use ice pack before injection to numb area
  • Inject in evening if nausea is problematic (sleep through worst of it)
  • Same day/time each week for consistency
What if I miss a dose?

For weekly injections (Semaglutide, Tirzepatide):

  • If <5 days late: Inject as soon as you remember, then resume normal schedule
  • If ≥5 days late: Skip the missed dose and inject on your next scheduled day
  • Never double dose to make up for a missed injection

For daily injections (Liraglutide):

  • If <12 hours late: Inject as soon as you remember
  • If ≥12 hours late: Skip the missed dose and resume normal schedule tomorrow
  • Never take two doses in the same day

⚠️ Important: Missing doses can cause side effects to return when you resume. Try to maintain consistency for best results and tolerability.

Can I increase my dose faster?

No, rapid dose increases cause severe nausea and vomiting.

The titration schedules are designed to allow your body to adapt gradually:

  • Tirzepatide: 20 weeks to reach maximum dose (2.5mg → 15mg)
  • Semaglutide: 16-20 weeks to reach maximum dose (0.25mg → 2.4mg)
  • Liraglutide: 5 weeks to reach maximum dose (0.6mg → 3.0mg)

If side effects are severe, stay at your current dose for 4-8 more weeks before increasing. There's no rush - slower titration often leads to better long-term adherence.

💡 Remember: You'll still lose weight on lower doses. The goal is to find the minimum effective dose that controls your appetite without causing intolerable side effects.

Results & Maintenance

What happens when I stop taking the medication?

Weight regain is common after stopping GLP-1 agonists.

Clinical trial data shows:

  • Patients regain 50-70% of lost weight within 1 year of stopping
  • Appetite returns to baseline (or higher) within 2-4 weeks
  • Metabolic rate remains suppressed from weight loss
  • Hormonal changes favor weight regain (increased ghrelin, decreased leptin)

Why this happens:

  • GLP-1 agonists don't "cure" obesity - they manage it
  • Your body's set point defends against weight loss
  • Lifestyle changes alone are often insufficient to maintain large weight losses
  • Metabolic adaptations make regain easier than initial loss

💡 Maintenance strategies:

  • Continue medication: Stay on maintenance dose indefinitely (most effective)
  • Reduce dose: Lower to minimum effective dose
  • Extend interval: Inject every 10-14 days instead of weekly
  • Discontinue with monitoring: Weigh weekly and restart if regain >5 lbs
Will I lose muscle mass?

Yes, rapid weight loss always includes some muscle loss.

Typical composition of weight loss:

  • Without resistance training: 70-75% fat, 25-30% muscle
  • With resistance training: 85-90% fat, 10-15% muscle

Why muscle loss occurs:

  • Caloric deficit causes body to break down both fat and muscle for energy
  • Rapid weight loss (>2 lbs/week) increases muscle loss
  • Insufficient protein intake accelerates muscle breakdown
  • Lack of resistance training signals body that muscle isn't needed

💡 Preserving muscle mass:

  • Resistance training: 3-4x per week (essential)
  • Protein intake: 80-120g daily (0.8-1.0g per lb of goal weight)
  • Adequate calories: Don't go below 1200 calories (women) or 1500 (men)
  • Slower weight loss: 1-2 lbs per week is ideal
  • Creatine supplementation: 5g daily may help preserve muscle
Can I drink alcohol while on these medications?

Alcohol is not contraindicated, but it's not recommended.

Why you should limit alcohol:

  • Increases nausea: Alcohol + GLP-1 agonists = severe nausea and vomiting
  • Slows weight loss: Empty calories that don't satisfy appetite
  • Hypoglycemia risk: Especially if you have diabetes
  • Dehydration: Compounds GI side effects
  • Poor food choices: Alcohol lowers inhibitions and increases cravings

If you choose to drink:

  • Limit to 1-2 drinks maximum
  • Drink slowly with food
  • Stay well-hydrated with water
  • Avoid drinking within 48 hours of dose increase
  • Monitor blood sugar if diabetic

⚠️ Many patients report: Alcohol tolerance decreases significantly on GLP-1 agonists. What used to be 2-3 drinks now feels like 5-6. Hangovers are also worse.

Cost & Practical Considerations

How much does treatment cost?

Retail pricing (without insurance):

  • Tirzepatide: $1,000-1,400/month ($12,000-16,800/year)
  • Semaglutide: $900-1,400/month ($10,800-16,800/year)
  • Liraglutide: $1,300-1,500/month ($15,600-18,000/year)

With insurance:

  • For diabetes: $25-100/month copay typically
  • For weight loss: Often not covered; if covered, $100-250/month copay

Compounded versions:

  • Cost: $200-400/month ($2,400-4,800/year)
  • Risks: Not FDA-approved, variable quality, no insurance coverage

Total treatment cost (68 weeks):

  • Brand name: $14,000-23,000
  • With insurance: $400-4,000
  • Compounded: $3,000-6,000
Are there any savings programs or coupons?

Yes, manufacturer savings programs can significantly reduce costs:

Wegovy (semaglutide for weight loss):

  • WeGovyRx Savings Card: $500-650/month savings
  • Reduces cost to $0-25/month for up to 13 fills
  • Requires commercial insurance (not Medicare/Medicaid)

Zepbound (tirzepatide for weight loss):

  • Zepbound Savings Card: Up to $550/month savings
  • Reduces cost to $25/month for up to 13 fills
  • Requires commercial insurance

Saxenda (liraglutide for weight loss):

  • Saxenda Savings Card: Up to $200/month savings
  • Reduces cost to as low as $25/month
  • Requires commercial insurance

⚠️ Important limitations:

  • Not available for Medicare/Medicaid patients
  • Not available for uninsured patients (must have commercial insurance)
  • Limited to 13 fills (approximately 1 year)
  • May not be available if insurance covers medication
Can I travel with these medications?

Yes, but proper storage and planning are essential.

Storage requirements:

  • Unopened pens: Must be refrigerated (36-46°F / 2-8°C)
  • In-use pens: Can be kept at room temperature (up to 86°F / 30°C) for 28-56 days depending on medication
  • Never freeze: Freezing destroys the medication
  • Protect from light: Keep in original packaging

Travel tips:

  • Carry-on only: Never check medication in luggage (temperature extremes)
  • Cooling case: Use insulated medication travel case with ice packs
  • Prescription label: Keep medication in original packaging with prescription label
  • Doctor's note: Carry letter from doctor explaining medical necessity
  • Extra supply: Bring backup pen in case of loss/damage
  • TSA: Inform security you're carrying refrigerated medication

💡 International travel: Check destination country's regulations. Some countries restrict or prohibit GLP-1 agonists. Contact embassy or consulate before traveling.

Ready to Get Started?

Use our tools to plan your weight loss journey

Calculate Your Dosing Schedule Compare Peptides

⚠️ Medical Disclaimer

This FAQ provides educational information only and should not replace consultation with a qualified healthcare provider. GLP-1 agonists are prescription medications that require medical supervision. Always consult with your doctor before starting, stopping, or changing any medication.